lunes, 5 de octubre de 2026
The law has to catch up on orphan-designated drugs with multiple uses Crohn’s disease is not juvenile idiopathic arthritis. Why does 340B treat them like they’re the same?
The law has to catch up on orphan-designated drugs with multiple uses
Crohn’s disease is not juvenile idiopathic arthritis. Why does 340B treat them like they’re the same?
https://www.statnews.com/2026/10/02/340b-policy-orphan-designated-drugs-pharmacy-losses-hrsa-congress/
By John MildenbergerOct. 2, 2026
Mildenberge is the specialty pharmacy manager, senior clinical lead pharmacist, and community pharmacy compliance officer at Sidney Regional Medical Center in Sidney, Neb.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario